Mizuho Maintains Outperform on NeuroPace, Lowers Price Target to $12

Benzinga · 5d ago
Mizuho analyst Anthony Petrone maintains NeuroPace (NASDAQ:NPCE) with a Outperform and lowers the price target from $22 to $12.